Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR

7.12  +0.21 (+2.96%)

Fundamental Rating

2

Overall OCI gets a fundamental rating of 2 out of 10. We evaluated OCI against 61 industry peers in the Chemicals industry. OCI may be in some trouble as it scores bad on both profitability and health. OCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year OCI has reported negative net income.
In the past year OCI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
In the past 5 years OCI always reported a positive cash flow from operatings.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

With a Return On Assets value of -5.28%, OCI is not doing good in the industry: 65.57% of the companies in the same industry are doing better.
OCI has a worse Return On Equity (-51.53%) than 78.69% of its industry peers.
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROIC N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

In the last couple of years the Profit Margin of OCI has grown nicely.
Looking at the Gross Margin, with a value of 2.23%, OCI is doing worse than 81.97% of the companies in the same industry.
OCI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

2

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
OCI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, OCI has more shares outstanding
Compared to 1 year ago, OCI has an improved debt to assets ratio.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

OCI has an Altman-Z score of 0.19. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.19, OCI is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 44.52, OCI is doing worse than 60.66% of the companies in the same industry.
A Debt/Equity ratio of 2.03 is on the high side and indicates that OCI has dependencies on debt financing.
OCI has a Debt to Equity ratio of 2.03. This is amonst the worse of the industry: OCI underperforms 85.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Altman-Z 0.19
ROIC/WACCN/A
WACC6.16%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

OCI has a Current Ratio of 1.39. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI's Current ratio of 1.39 is on the low side compared to the rest of the industry. OCI is outperformed by 65.57% of its industry peers.
A Quick Ratio of 1.37 indicates that OCI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.37, OCI is in the better half of the industry, outperforming 67.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.37
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.19%.
The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
OCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.51%.
Measured over the past years, OCI shows a very negative growth in Revenue. The Revenue has been decreasing by -20.30% on average per year.
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%

3.2 Future

OCI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.49% yearly.
OCI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.74% yearly.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-4.1%
Revenue Next 2Y1.62%
Revenue Next 3Y-4.5%
Revenue Next 5Y-1.74%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

OCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 18.26, the valuation of OCI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, OCI is valued a bit cheaper than 62.30% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OCI to the average of the S&P500 Index (21.38), we can say OCI is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 18.26
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as OCI.
Industry RankSector Rank
P/FCF 31.76
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%

0

5. Dividend

5.1 Amount

OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OCI NV

AMS:OCI (4/25/2025, 7:00:00 PM)

7.12

+0.21 (+2.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-14 2025-03-14/amc
Earnings (Next)05-20 2025-05-20
Inst Owners32.2%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.50B
Analysts80
Price Target14.02 (96.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend13.42
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)0%
PT rev (3m)1.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.26
P/S 0.38
P/FCF 31.76
P/OCF 3.1
P/B 1.86
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)0.39
Fwd EY5.48%
FCF(TTM)0.22
FCFY3.15%
OCF(TTM)2.3
OCFY32.3%
SpS18.93
BVpS3.83
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.23%
FCFM 1.18%
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Debt/EBITDA N/A
Cap/Depr -4159.17%
Cap/Sales 10.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.37
Altman-Z 0.19
F-Score3
WACC6.16%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-4.1%
Revenue Next 2Y1.62%
Revenue Next 3Y-4.5%
Revenue Next 5Y-1.74%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.92%
EBIT Next 3Y25.04%
EBIT Next 5Y23.97%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%